What is the Medicare price of cabozantinib in 2024?

Cabozantinib (Cabozantinib) is a multi-target oral small molecule tyrosine kinase inhibitor mainly used to treat a variety of solid tumors, including thyroid cancer, renal cancer and hepatocellular carcinoma. Due to its remarkable efficacy, cabozantinib has been widely used clinically. Cabozantinib effectively inhibits the growth and metastasis of tumor cells by inhibiting multiple key signaling pathways, including the activity of receptor tyrosine kinases such as MET, VEGFR, RET, KIT, and AXL. However, due to its high research and development costs, the price of cabozantinib is also relatively expensive.

Regarding the medical insurance price of cabozantinib, there may be differences in different countries and regions. In some countries, cabozantinib has been included in the medical insurance catalog, and patients can reimburse part of the cost through medical insurance. However, due to different medical insurance policies and reimbursement ratios, the specific medical insurance prices will also vary. In China, the original drug cabozantinib has not yet been included in the national medical insurance directory, so it cannot be reimbursed through medical insurance. However, hospitals or pharmacies in some areas may also provide cabozantinib discounts or charity drug donation programs to reduce the financial burden on patients.

Overseas versions have been launched in Japan, Türkiye and Europe, in tablet and capsule forms. The price of 60mg*30 tablets may exceed RMB 30,000, while the price of (20mg+80mg)*112 capsules may exceed RMB 40,000 (prices may fluctuate due to exchange rate changes). At the same time, there are also generic cabozantinib drugs in overseas markets. For example, the version produced in Bangladesh costs only more than 2,000 yuan. Its ingredients are basically the same as the original drug and the price is affordable.